3rd Quarter - Report

THE LIVINGSTON GROUP, LLC for PKD FOUNDATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Request research and clinical funding for PKD under the competitive Defense Peer Reviewed Medical Research Program under the FY 2009 Defense Appropriations bill (H.R. 2638 as enacted); PKD report language to establish PKD Clinical and Diagnostic Treatment Centers in the NIH/NIDDK section of FY09 LHHS Approps bill (House Labor HHS subcommittee report, no bill intro'd, and S.3230) language to fund the expansion of PKD-specific patient services, education and empowerment initiatives that will support patient education, disease management and outreach in the HHS section of the FY 2009 Labor/HHS/Education Appropriations bill (House Labor HHS subcommittee report, no bill intro'd); support passage of the National PKD Awareness Week Resolution for 2008 (passed in the Senate as S.Res 620).

LobbyistCovered position, as disclosed
ROBERT L LIVINGSTON Frmr Rep., US House
J ALLEN MARTIN Frmr COS., Cong. Livingston

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Res. 620 (110th), H.R. 2638 (110th), S. 3230 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.